Holtzman DM - Search Results

1

A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer's disease.

Moore KM, Girens RE, Larson SK, Jones MR, Restivo JL, Holtzman DM, Cirrito JR, Yuede CM, Zimmerman SD, Timson BF. Moore KM, et al. Among authors: holtzman dm. Neurobiol Dis. 2016 Jan;85:218-224. doi: 10.1016/j.nbd.2015.11.004. Epub 2015 Nov 10. Neurobiol Dis. 2016. PMID: 26563933

2

Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury.

Ferriero DM, Holtzman DM, Black SM, Sheldon RA. Ferriero DM, et al. Among authors: holtzman dm. Neurobiol Dis. 1996 Feb;3(1):64-71. doi: 10.1006/nbdi.1996.0006. Neurobiol Dis. 1996. PMID: 9173913

3

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.

Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, Chang LK, Sun Y, Paul SM. Holtzman DM, et al. J Clin Invest. 1999 Mar;103(6):R15-R21. doi: 10.1172/JCI6179. J Clin Invest. 1999. PMID: 10079115 Free PMC article.

4

Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.

Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT. Holtzman DM, et al. Ann Neurol. 2000 Jun;47(6):739-47. Ann Neurol. 2000. PMID: 10852539

5

Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice.

DeMattos RB, Brendza RP, Heuser JE, Kierson M, Cirrito JR, Fryer J, Sullivan PM, Fagan AM, Han X, Holtzman DM. DeMattos RB, et al. Among authors: holtzman dm. Neurochem Int. 2001 Nov-Dec;39(5-6):415-25. doi: 10.1016/s0197-0186(01)00049-3. Neurochem Int. 2001. PMID: 11578777

6

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM. DeMattos RB, et al. Among authors: holtzman dm. Science. 2002 Mar 22;295(5563):2264-7. doi: 10.1126/science.1067568. Science. 2002. PMID: 11910111

7

Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.

Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM. Fagan AM, et al. Among authors: holtzman dm. Neurobiol Dis. 2002 Apr;9(3):305-18. doi: 10.1006/nbdi.2002.0483. Neurobiol Dis. 2002. PMID: 11950276

8

Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.

DeMattos RB, O'dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, Paul SM, Aronow BJ, Holtzman DM. DeMattos RB, et al. Among authors: holtzman dm. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10843-8. doi: 10.1073/pnas.162228299. Epub 2002 Jul 26. Proc Natl Acad Sci U S A. 2002. PMID: 12145324 Free PMC article.

9

Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.

Hartman RE, Laurer H, Longhi L, Bales KR, Paul SM, McIntosh TK, Holtzman DM. Hartman RE, et al. Among authors: holtzman dm. J Neurosci. 2002 Dec 1;22(23):10083-7. doi: 10.1523/JNEUROSCI.22-23-10083.2002. J Neurosci. 2002. PMID: 12451108 Free PMC article.

10

Abeta conformational change is central to Alzheimer's disease.

Holtzman DM. Holtzman DM. Neurobiol Aging. 2002 Nov-Dec;23(6):1085-8. doi: 10.1016/s0197-4580(02)00040-4. Neurobiol Aging. 2002. PMID: 12470806 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

727 results

Search Page

Filters